Skip to main content
Premium Trial:

Request an Annual Quote

Elias Caro, Andrew Carr

Elias Caro, executive vice president of international diagnostics and global life sciences commercial operations at Beckman Coulter, has retired effective July 31, according to an 8-K filing with the US Securities and Exchange Commission. Caro will receive biweekly payments of $12,516.67 for a 17-month period that began Aug. 1, a prorated bonus for 2006 at target plus a lump sum payment of 10 percent of the bonus to reflect retirement plan contributions that would have been made had he continued to be employed, according to the filing.

Deltadot appointed Andrew Carr as chairman of its board this week.

Previously, Carr was a director of Amersham and CEO of Amersham Biosciences. He has been executive chairman and is now the non-executive chairman of Akubio.

He received his PhD in zoology from the
University of

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.